1-12 of 12
Katarina Uttervall
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Outcomes of Relapsed and Refractory Multiple Myeloma with the Evolving Standard of Care

Vincent Luong, Muhammad Kashif, Katarina Uttervall, Anna Bohlin, Nursen Cetrez, Gabriel Afram, Hareth Nahi, Johan Lund, Evren Alici
Journal: Blood
Blood (2024) 144 (Supplement 1): 3320.
https://doi.org/10.1182/blood-2024-193255
Published: 2024
Journal Articles

A Lightweight Risk Scoring System for Stratification of Newly Diagnosed Multiple Myeloma Patients

Georgia Riga, Vincent Luong, Katarina Uttervall, Gösta Gahrton, Hareth Nahi, Johan Lund, Evren Alici, Muhammad Kashif
Journal: Blood
Blood (2024) 144 (Supplement 1): 3318.
https://doi.org/10.1182/blood-2024-209504
Published: 2024
Journal Articles

Analysis of Repeat Step-up Dosing and Cytokine Release Syndrome Events Following Prolonged Dosing Intervals of Teclistamab in the Phase 1/2 Majestec-1 Study

Niels W.C.J. van de Donk, Ajai Chari, Lionel Karlin, Amrita Y Krishnan, Katarina Uttervall, Thomas Chalopin, Laura Rosinol Dachs, Albert Oriol, Jeffrey V Matous, Manisha Bhutani, Cesar Rodriguez, Natalia A Quijano Cardé, Yue Guo, Caroline Hodin, Clarissa Uhlar, Tara Stephenson, Athena Zuppa, Margaret Doyle, Katherine Chastain, Alfred L Garfall
Journal: Blood
Blood (2024) 144 (Supplement 1): 4734.
https://doi.org/10.1182/blood-2024-200344
Published: 2024
Journal Articles

Higher Teclistamab Step-up Dosing in Patients with Relapsed or Refractory Multiple Myeloma (RRMM): Results from the Majestec-1 Trial

Jeffrey V Matous, Niels W.C.J. van de Donk, Albert Oriol, Alfred L. Garfall, Paula Rodríguez-Otero, Thomas Chalopin, Laura Rosinol Dachs, Katarina Uttervall, Maria- Victoria Mateos, Danielle Trancucci, Natalia Quijano Cardé, Caroline Hodin, Tara Stephenson, Athena Zuppa, Katherine Chastain, Lionel Karlin
Journal: Blood
Blood (2024) 144 (Supplement 1): 4749.
https://doi.org/10.1182/blood-2024-204007
Published: 2024
Journal Articles

Phase 3 Randomized Study of Daratumumab Monotherapy Versus Active Monitoring in Patients with High-Risk Smoldering Multiple Myeloma: Primary Results of the Aquila Study

Meletios-Athanasios Dimopoulos, Peter M. Voorhees, Fredrik Schjesvold, Yael C. Cohen, Vania Hungria, Irwindeep Sandhu, Jindriska Lindsay, Ross Ian Baker, Kenshi Suzuki, Hiroshi Kosugi, Mark-David Levin, Meral Beksac, Keith Stockerl-Goldstein, Albert Oriol, Gabor Mikala, Gonzalo Martin Garate, Koen Theunissen, Ivan Spicka, Anne K. Mylin, Sara Bringhen, Katarina Uttervall, Bartosz Michal Pula, Eva Medvedova, Andrew J. Cowan, Philippe Moreau, Maria-Victoria Mateos, Hartmut Goldschmidt, Tahamtan Ahmadi, Linlin Sha, Els Rousseau, Liang Li, Robyn M. Dennis, Robin Carson, Vincent Rajkumar
Journal: Blood
Blood (2024) 144 (Supplement 1): 773.
https://doi.org/10.1182/blood-2024-201057
Published: 2024
Journal Articles

Predictive Biosignature and Risk Scoring for Bone Disease in Multiple Myeloma

Muhammad Kashif, Niki Throumpari, Katarina Uttervall, Kristin Roseth Aass, Therese Standal, Kristine Misund, Hareth Nahi, Robin Mjelle, Evren Alici, Johan Lund
Journal: Blood
Blood (2024) 144 (Supplement 1): 4686.
https://doi.org/10.1182/blood-2024-202992
Published: 2024
Journal Articles

A Novel Biosignature for Potential Stratification and Elucidation of Newly Diagnosed Multiple Myeloma Patients at-Risk

Muhammad Kashif, Yijie Zhou, Vincent Luong, Katarina Uttervall, Gösta Gahrton, Hareth Nahi, Evren Alici, Johan Lund
Journal: Blood
Blood (2023) 142 (Supplement 1): 1960.
https://doi.org/10.1182/blood-2023-179999
Published: 2023
Journal Articles

Teclistamab for Relapsed/Refractory Multiple Myeloma: Real-World Experience in an Early Access Program

Katarina Uttervall, Hareth Nahi, Muhammad Kashif, Konstantinos Lemonakis, Sara Rosengren, Janaki Brolin, Johan Lund, Markus Hansson
Journal: Blood
Blood (2022) 140 (Supplement 1): 12605–12606.
https://doi.org/10.1182/blood-2022-158801
Published: 2022
Journal Articles

DREAMM-5 Study: Investigating the Synergetic Effects of Belantamab Mafodotin Plus Inducible T-Cell Co-Stimulator Agonist (aICOS) Combination Therapy in Patients with Relapsed/Refractory Multiple Myeloma

Natalie S. Callander, Vincent Ribrag, Paul G. Richardson, Ajay K. Nooka, Kevin Song, Katarina Uttervall, Monique C. Minnema, Katja Weisel, Hang Quach, Chang-Ki Min, Marc S. Ballas, Xiaofang Li, Nirav Ratia, Morrys Kaisermann, Beata Holkova, Suzanne Trudel
Journal: Blood
Blood (2021) 138 (Supplement 1): 897.
https://doi.org/10.1182/blood-2021-152662
Published: 2021
Journal Articles

Is Multiple Myeloma a Chronic Disease? A Population Based Study Comparing 1843 Patients to a Matched Swedish Population.

Hareth Nahi, Johan Liwing, Anders Aldrin, Johan Andreasson, Cecilie Blimark, MD, Kristina Carlson, Jon Enestig, Max Flogegård, Karin Forsberg, Astrid Gruber, MD, PhD, Peter Johansson, MD, PhD, Helene Kviele, Birgitta Lauri, Ulf-Henrik Mellqvist, MD, PhD, Per Näsman, Agneta Swedin, Magnus Svensson, Katarina Uttervall, MD, PhD-student, Johan Aschan, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 2970.
https://doi.org/10.1182/blood.V120.21.2970.2970
Published: 2012
Journal Articles

Is Renal Impairment Still a Poor Prognostic Marker in Myeloma Care?: A Population Based Study Including 1542 Patients

Katarina Uttervall, MD, PhD-student, Johan Andreasson, Johan Liwing, Per Näsman, Johan Aschan, MD, PhD, Hareth Nahi
Journal: Blood
Blood (2012) 120 (21): 5033.
https://doi.org/10.1182/blood.V120.21.5033.5033
Published: 2012
Journal Articles

Follow-up of Real Life Treated Multiple Myeloma Patients: Response, Disease Progression and Overall Survival,

Hareth Nahi, Johan Liwing, Katarina Uttervall, Johan Andreasson, Astrid Gruber, MD, PhD, Per Näsman, Johan Aschan
Journal: Blood
Blood (2011) 118 (21): 3937.
https://doi.org/10.1182/blood.V118.21.3937.3937
Published: 2011